Azlocillin
File:Azlocillin skeletal.svg | |
Systematic (IUPAC) name | |
---|---|
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(2R)-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 37091-66-0 ![]() |
ATC code | J01CA09 (WHO) |
PubChem | CID: 6479523 |
DrugBank | DB01061 ![]() |
ChemSpider | 4980416 ![]() |
UNII | HUM6H389W0 ![]() |
KEGG | D02339 ![]() |
ChEBI | CHEBI:2956 ![]() |
ChEMBL | CHEMBL1537 ![]() |
Chemical data | |
Formula | C20H23N5O6S |
Molecular mass | 461.491 g/mol |
|
|
|
|
(verify) |
Azlocillin is an acylampicillin antibiotic with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin is similar to mezlocillin and piperacillin. It demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa and, in contrast to most cephalosporins, exhibits activity against enterococci.
Spectrum of bacterial susceptibility
Azlocillin is considered a broad spectrum antibiotic and can be used against a number of Gram positive and Gram negative bacteria. The following represents MIC susceptibility data for a few medically significant organisms.[1]
- Escherichia coli 1 μg/mL – 32 μg/mL
- Haemophilus spp. 0.03 μg/mL – 2 μg/mL
- Pseudomonas aeruginosa 4 μg/mL – 6.25 μg/mL
Synthesis
An interesting alternative synthesis of azlocillin involves activation of the substituted phenylglycine analogue 1 with 1,3-dimethyl-2-chloro-1-imidazolinium chloride (2) and then condensation with 6-APA.
See also
References
- ↑ http://www.toku-e.com/Assets/MIC/Azlocillin%20sodium%20salt.pdf
- ↑ 2.0 2.1 H. B. Konig et al., Eur. J. Med. Chem. - Chim. Ther. 17, 59 (1982).
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>